AdobeStock 45152025

Bio-Rad secures IVDR certification for molecular quality controls portfolio

Bio-Rad Laboratories has achieved a significant regulatory milestone with EU Quality Management Systems certification under the In Vitro Diagnostic Regulation (IVDR), enabling CE marking for 40 infectious disease molecular quality control products from their Exact Diagnostics brand.

AdobeStock 526319505

Revvity expands genomic sequencing services with Genomics England in landmark newborn screening programme

Revvity, Inc. has significantly expanded its collaboration with Genomics England to provide comprehensive genomic screening services for newborns in England. The new agreement builds upon an existing partnership by adding DNA sequencing services to Revvity’s current DNA extraction capabilities.

Amy Walker, COO of 4basebio

4basebio secures MHRA GMP certification for synthetic DNA production

Cambridge-based 4basebio has received Good Manufacturing Practice certification from the UK’s Medicines and Healthcare products Regulatory Agency, enabling the company to supply GMP-grade synthetic DNA for clinical applications in cell and gene therapy development.

Billy and ReCIVA

Cystic Fibrosis Foundation invests in Owlstone to develop breath test for Pseudomonas detection

The Cystic Fibrosis Foundation has committed up to US$2.3 million (about £1.7 million) in equity investment to Owlstone Medical for the development of a breath test to detect Pseudomonas aeruginosa (PA) infections in people with cystic fibrosis (CF). The Cambridge-based company announced the investment on March 25, 2025, marking a significant step forward in respiratory […]

T1 diabetes

Simple blood test measures type 1 diabetes autoimmunity in children

Innovative assay requires minimal blood sample while providing high accuracy

Scherm­afbeelding 2025 03 24 om 11.39.57

Diasys Respons C-Line

Leading the way in laboratory excellence

CLI 250317 doc imatge complements

C1q, C1 Inhibitor, C5 and Factor B assays for Turbidimetry and Nephelometry

TRIMERO Diagnostics offers C1q, C5, C1 (Esterase) Inhibitor and Factor B (C3 Proactivator) IVD CE marked assays on: Clinical Chemistry Analyzers Binding Site’s Optilite® Analyzer Siemens Healthcare’s BN™ Series and Atellica® NEPH 630 nephelometers Beckman Coulter’s IMMAGE® 800 Immunochemical Systems

Finland launches pioneering medical device pilot line to accelerate patient-friendly innovations

Finland launches pioneering medical device pilot line to accelerate patient-friendly innovations

A state-of-the-art pilot line environment established by VTT Technical Research Centre of Finland aims to bridge the critical gap between medical technology research and market-ready products, potentially reducing development timelines for non-invasive diagnostic and monitoring devices.

AdobeStock 844411873

Deep quantitative glycoprofiling: new method for fast, sensitive and in-depth mass spectrometry of protein glycosylation

What is protein glycosylation? There are several types of post-translational modifications (PTMs) that proteins can undergo. Phosphorylation, methylation and acetylation all involve the addition of small chemical groups which affect function. Ubiquitylation involves the addition of the small peptide, ubiquitin, which targets proteins for degradation. Glycosylation is one of the more complex forms of PTM, […]

Curiox Biosystems

Curiox biosystems launches affordable cell washing automation system

Curiox Biosystems has launched a new automated cell washing system that eliminates centrifugation to enhance cell viability whilst streamlining laboratory workflows. The Curiox C-Free Pluto ALPHA represents an advancement in sample preparation technology with potential applications in immunophenotyping, cell therapy development, and drug discovery research.